Ownership history in Solutions 4 Wealth, Ltd · 9 quarters on record
This page tracks every 13F SEC filing in which Solutions 4 Wealth, Ltd reported a position in GALECTIN THERAPEUTICS INC (GALT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | UNCHANGED | 25,377 | — | 0% | 0.16% | $106K | $4.16 |
| 2025 Q3 | REDUCED | 25,377 | -10,626 | -29.5% | 0.17% | $107K | $4.24 |
| 2025 Q2 | UNCHANGED | 36,003 | — | 0% | 0.13% | $76K | $2.11 |
| 2025 Q1 | UNCHANGED | 36,003 | — | 0% | 0.08% | $44K | $1.22 |
| 2024 Q4 | UNCHANGED | 36,003 | — | 0% | 0.08% | $46K | $1.29 |
| 2024 Q3 | REDUCED | 36,003 | -82 | -0.2% | 0.19% | $99K | $2.75 |
| 2024 Q2 | UNCHANGED | 36,085 | — | 0% | 0.18% | $82K | $2.26 |
| 2024 Q1 | UNCHANGED | 36,085 | — | 0% | 0.24% | $86K | $2.39 |
| 2023 Q4 | INITIATED | 36,085 | — | — | 0.20% | $60K | — |
As of 2025 Q4 — sorted by position size